1-3 of 3
Obada Ababneh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma

Samer Al Hadidi, Obada Ababneh, Carson W Ercanbrack, Carolina Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert Smith, Susan Panozzo, Guido Tricot, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Maurizio Zangari, Frits van Rhee
Journal: Blood
Blood (2023) 142 (Supplement 1): 3594.
https://doi.org/10.1182/blood-2023-181034
Published: 2023
Journal Articles

Variability of Definition of High-Risk Multiple Myeloma in Phase III Clinical Trials

Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi
Journal: Blood
Blood (2022) 140 (Supplement 1): 10116–10117.
https://doi.org/10.1182/blood-2022-158188
Published: 2022
Journal Articles

The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials

Obada Ababneh, Faris Jamal Abu Za'nouneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi
Journal: Blood
Blood (2022) 140 (Supplement 1): 12532–12533.
https://doi.org/10.1182/blood-2022-158282
Published: 2022